Dr CLAVIER Jean-Baptiste

5-year results of hypofractionated locoregional radiotherapy in early breast cancer HypoG-01 (UNICANCER): a French multicentre, randomised, non-inferiority, phase 3, open-label, controlled trial.

Rivera S, Ghodssighassemabadi R, Auzac G, Brion T, Kirova Y, Racadot S, Benchalal M, Clavier JB, Charra Brunaud C, Groulier A, Argo-Leignel D, Peignaux K, Benyoucef A, Pasquier D, Guilbert P, Goineau A, Tallet A, Bergeaud M, Lamrani-Ghaouti A, Michiels S,

Lancet. 2026 03 7;407(10532):976-987

Early toxicity of moderately hypofractionated radiation therapy in breast cancer patients receiving locoregional irradiation: First results of the UNICANCER HypoG-01 phase III trial.

Brion T, Ghodssighassemabadi R, Auzac G, Kirova Y, Racadot S, Benchalal M, Clavier JB, Brunaud C, Fouche-Chand ME, Argo-Leignel D, Peignaux-Casasnovas K, Benyoucef A, Pasquier D, Guilbert P, Blanchecotte J, Tallet-Richard A, Lamrani A, Bergeau M, Bielynite G, Ruffier A, Karamouza E, Michiels S, Rivera S

Radiother Oncol. 2025 03 15;:110849

Bayesian Network structure learning algorithm for highly missing and non imputable data: Application to breast cancer radiotherapy data.

Piot M, Bertrand F, Guihard S, Clavier JB, Maumy M

Artif Intell Med. 2024 01;147:102743

[Real world data in radiotherapy: A data farming project by Unitrad].

Guihard S, Piot M, Issoufaly I, Giraud P, Bruand M, Faivre JC, Eugène R, Liem X, Pasquier D, Lamrani-Ghaouti A, Ghannam Y, Ruffier A, Guilbert P, Larnaudie A, Thariat J, Rivera S, Clavier JB

Cancer Radiother. 2023 07 28;:

Acute skin toxicity of conventional fractionated versus hypofractionated radiotherapy in breast cancer patients receiving regional node irradiation: the real-life prospective multicenter HYPOBREAST cohort.

Bruand M, Salleron J, Guihard S, Crety CM, Liem X, Pasquier D, Lamrani-Ghaouti A, Charra-Brunaud C, Peiffert D, Clavier JB, Desandes E, Faivre JC

BMC Cancer. 2022 12 16;22(1):1318

Favorable safety profile of moderate hypofractionated over normofractionated radiotherapy in breast cancer patients: a multicentric prospective real-life data farming analysis.

Issoufaly I, Petit C, Guihard S, Eugène R, Jung L, Clavier JB, Servagi Vernat S, Bellefqih S, Verret B, Bonnet N, Deutsch É, Rivera S

Radiat Oncol. 2022 Apr 20;17(1):80

[Prognostic factors of acute radiodermatitis in breast cancer after adjuvant radiotherapy treated with RT3D or IMRT].

Thomas A, Keller A, Menoux I, Brahimi Y, Vigneron C, Le Fèvre C, Chambrelant I, Pietta GA, Guihard S, Clavier JB, Antoni D, Noël G

Cancer Radiother. 2022 Feb 25;:

Dose-Response Effect and Dose-Toxicity in Stereotactic Radiotherapy for Brain Metastases: A Review.

Loo M, Clavier JB, Attal Khalifa J, Moyal E, Khalifa J

Cancers (Basel). 2021 Dec 2;13(23):

Anxiety during Radiation Therapy: A Prospective Randomized Controlled Trial Evaluating a Specific One-on-One Procedure Announcement Provided by a Radiation Therapist.

Antoni D, Vigneron C, Clavier JB, Guihard S, Velten M, Noel G

Cancers (Basel). 2021 May 24;13(11):

Clavier JB, Jung L, Eugène R, Mazzara C, Servagi S, Rivera S, Issoufaly I, Bellefqih S, Hannoun-Lévi JM, Petit C, Feuillade J, Fontbonne JM, Bonnet N, Jou A, Piot M, Liem X, Thariat J, Guihard S

Cancer Radiother. 2020 Oct;24(6-7):774-775

Issoufaly I, Rivera S, Guihard S, Clavier JB, Rémi E, Vigneron C, Menoux I, Mazzara C, Servagi Vernat S, Bellefquih S, Petit C

Cancer Radiother. 2020 Oct;24(6-7):780

Jou A, Guihard S, Fontbonne JM, Clavier JB, Fontbonne C, Mazzara C, Eugène R, Piot M, Jung L, Thariat J

Cancer Radiother. 2020 Oct;24(6-7):780-781

Single-fraction radiosurgery versus fractionated stereotactic radiotherapy in patients with brain metastases: a comparative study.

Loo M, Pin Y, Thierry A, Clavier JB

Clin. Exp. Metastasis. 2020 Mar 17;:

Brain Metastasis and Renal Cell Carcinoma: Prognostic Scores Assessment in the Era of Targeted Therapies.

El Ali Z, Rottey S, Barthelemy P, Kotecki N, VAN Paemel R, Devrient D, Awada A, Gil T, Pannier D, Ryckewaert T, Waisse W, Clavier JB, Penel N, Vermassen T

Anticancer Res.. 2019 Jun;39(6):2993-3002

Practical contouring guidelines with an MR-based atlas of brainstem structures involved in radiation-induced nausea and vomiting.

Beddok A, Faivre JC, Coutte A, Guévelou JL, Welmant J, Clavier JB, Guihard S, Janoray G, Calugaru V, Pointreau Y, Lacout A, Salleron J, Lefranc M, Hasboun D, Duvernoy HM, Thariat J

Radiother Oncol. 2018 Aug 29;:

Automatic detection and segmentation of brain metastases on multimodal MR images with a deep convolutional neural network.

Charron O, Lallement A, Jarnet D, Noblet V, Clavier JB, Meyer P

Comput. Biol. Med.. 2018 Apr 1;95:43-54

[Radiotherapy of bone metastases in France: A descriptive monocentric retrospective study].

Le Fèvre C, Antoni D, Thiéry A, Keller A, Truntzer P, Vigneron C, Clavier JB, Guihard S, Pop M, Schumacher C, Salze P, Noël G

Cancer Radiother. 2018 Apr;22(2):148-162

[Risk of radionecrosis after hypofractionated stereotactic radiotherapy targeting the postoperative resection cavity of brain metastases].

Keller A, Doré M, Antoni D, Menoux I, Thillays F, Clavier JB, Delpon G, Jarnet D, Bourrier C, Lefebvre F, Chibbaro S, Darié I, Proust F, Noël G

Cancer Radiother. 2017 May;:

[Spinal stereotactic body radiotherapy: French assessment in 2016].

Pougnet I, Jaegle E, Garcia R, Tessier F, Faivre JC, Louvel G, Gross E, Gonzague L, Benchalal M, Ducteil A, Supiot S, Autret D, Clavier JB, Mirabel X, Bellière A, Wdowczyk D, Heymann S, Barillot I, de La Lande B, Passerat V, Sunyach MP, Lipinski F, Thibouw D, Guichard F, Chauvet B, Thariat J, Arnaud A

Cancer Radiother. 2017 May;:

[Big data and their perspectives in radiation therapy].

Guihard S, Thariat J, Clavier JB

Bull Cancer. 2017 Feb;104(2):147-156

An unusual pituitary stalk lesion: What is the place of surgery?

Todeschi J, Chibbaro S, Clavier JB, Lhermitte B, Goichot B, Proust F

Neurochirurgie. 2016 Dec;62(6):339-343

[Frameless set-up with ExacTrac(®) system for stereotactic radiotherapy of brain metastasis: Descriptive study from five French centres].

Ohnleiter T, Mahé MA, Biau J, Wdowczyk D, Clavier JB, Antoni D, Noël G

Cancer Radiother. 2016 Dec;20(8):768-775

Patterns of relapse in patients with high grade glioma receiving combined treatments including stereotactic re-irradiation for a first relapse.

Antoni D, Jastaniah Z, Haoming QC, Gaultier C, Ahle G, Couchot J, Atlani D, Schott R, Clavier JB, Srour R, Chaussemy D, Noël G

Cancer Radiother. 2016 Jun;20(4):282-91

Baseline nutritional status is prognostic factor after definitive radiochemotherapy for esophageal cancer.

Clavier JB, Antoni D, Atlani D, Ben Abdelghani M, Schumacher C, Dufour P, Kurtz JE, Noel G

Dis Esophagus. 2014 Aug;27(6):560-7

Age impacts the pattern of care for elderly patients with rectal cancer.

Guillerme F, Clavier JB, Nehme-Schuster H, Leroy V, Heitz D, Schumacher C, Abdelghani MB, Brigand C, Kurtz JE, Noel G

Int J Colorectal Dis. 2014 Feb;29(2):157-63

3D radiation therapy boost improves the outcome of whole brain radiation therapy treated RPA II patients with one or two brain metastases.

Antoni D, Clavier JB, Pop M, Schumacher C, Lefebvre F, Noel G

Int J Mol Sci. 2014 May 2;15(5):7554-62

[An analysis of 20 consecutive patients treated with stereotactic body radiotherapy on Novalis Tx((R)) for stage I non-small-cell lung cancer].

Guillerme F, Clavier JB, Schumacher C, Falcoz PE, Bourrhala K, Santelmo N, Hassler S, Schott R, Quoix E, Massard G, Noel G

Cancer Radiother. 2013 Jul-Aug;17(4):272-81

[Definitive chemoradiotherapy for esophageal cancer: 66Gy versus 50Gy, a retrospective study].

Clavier JB, Antoni D, Atlani D, Ben Abdelghani M, Schumacher C, Salze P, Noel G

Cancer Radiother. 2013 Jun;17(3):221-8

Early evaluation predicts pain relief of irradiated bone metastases: a single-center prospective study.

Truntzer P, Atlani D, Pop M, Clavier JB, Guihard S, Schumacher C, Noel G

BMC Palliat Care. 2013 Mar 13;12:12

Waiting times before initiation of radiotherapy might not affect outcomes for patients with glioblastoma: a French retrospective analysis of patients treated in the era of concomitant temozolomide and radiotherapy.

Noel G, Huchet A, Feuvret L, Maire JP, Verrelle P, Le Rhun E, Aumont M, Thillays F, Sunyach MP, Henzen C, Missohou F, de Crevoisier R, Bondiau PY, Collin P, Durando X, Truc G, Kerr C, Bernier V, Clavier JB, Atlani D, D'Hombres A, Vinchon-Petit S, Lagrange JL, Taillandier L

J Neurooncol. 2012 Aug;109(1):167-75